O3-04-01: Safety and efficacy of tarenflurbil in subjects with mild Alzheimer's disease: Results from an 18-month multi-center phase 3 trial

✍ Scribed by Robert C. Green; Lon S. Schneider; Suzanne B. Hendrix; Kenton H. Zavitz; Edward Swabb

• Book ID: 118464039
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 55 KB
• Volume: 4
• Category: Article
• ISSN: 1552-5260
• DOI: 10.1016/j.jalz.2008.05.432